Trial Profile
Randomized,Double Blind,Double Dummy, Multi-center Study of Efficacy and Safety of HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Oct 2018
Price :
$35
*
At a glance
- Drugs Hyzetimibe (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Zhejiang Hisun Pharmaceutical
- 17 Oct 2018 Status changed from active, no longer recruiting to completed.
- 15 Feb 2018 New trial record